These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28179210)
41. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum. Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726 [TBL] [Abstract][Full Text] [Related]
42. 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Lundqvist J; Yde CW; Lykkesfeldt AE Steroids; 2014 Jul; 85():30-5. PubMed ID: 24747771 [TBL] [Abstract][Full Text] [Related]
43. 24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Seo EG; Einhorn TA; Norman AW Endocrinology; 1997 Sep; 138(9):3864-72. PubMed ID: 9275076 [TBL] [Abstract][Full Text] [Related]
44. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699 [TBL] [Abstract][Full Text] [Related]
45. Optimization of Chemical Syntheses of Vitamin D C3-Epimers. Kattner L; Rauch E Anticancer Res; 2016 Mar; 36(3):1417-21. PubMed ID: 26977045 [TBL] [Abstract][Full Text] [Related]
46. Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Cohen ML; Douvdevani A; Chaimovitz C; Shany S Kidney Int; 2001 Jan; 59(1):69-75. PubMed ID: 11135059 [TBL] [Abstract][Full Text] [Related]
48. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3. Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568 [TBL] [Abstract][Full Text] [Related]
49. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis. Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783 [TBL] [Abstract][Full Text] [Related]
50. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Miller GJ; Stapleton GE; Hedlund TE; Moffat KA Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072 [TBL] [Abstract][Full Text] [Related]
51. Interleukin-1alpha and beta in growth plate cartilage are regulated by vitamin D metabolites in vivo. Dean DD; Schwartz Z; Muniz OE; Arsenis CH; Boyan BD; Howell DS J Bone Miner Res; 1997 Oct; 12(10):1560-9. PubMed ID: 9333116 [TBL] [Abstract][Full Text] [Related]
52. 25-Hydroxy- and 1α,25-Dihydroxycholecalciferol Have Greater Potencies than 25-Hydroxy- and 1α,25-Dihydroxyergocalciferol in Modulating Cultured Human and Mouse Osteoblast Activities. Zarei A; Hulley PA; Sabokbar A; Javaid MK; Morovat A PLoS One; 2016; 11(11):e0165462. PubMed ID: 27893751 [TBL] [Abstract][Full Text] [Related]
53. Analysis of vitamin D and its metabolites using thermospray liquid chromatography/mass spectrometry. Watson D; Setchell KD; Ross R Biomed Chromatogr; 1991 Jul; 5(4):153-60. PubMed ID: 1655127 [TBL] [Abstract][Full Text] [Related]
54. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases. Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471 [TBL] [Abstract][Full Text] [Related]
55. Novel analogs of 1,25-dihydroxyvitamin D Nachliely M; Sharony E; Kutner A; Danilenko M J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological activity of the 1alpha,25-dihydroxyvitamin D3 diastereomer with unnatural configuration at the rings C/D side-chain moiety. Marczak S; Przezdziecka A; Wicha J; Steinmeyer A; Zügel U Bioorg Med Chem Lett; 2001 Jan; 11(1):63-6. PubMed ID: 11140735 [TBL] [Abstract][Full Text] [Related]
57. Investigation of Vitamin D Schmitz LM; Kinner A; Althoff K; Rosenthal K; Lütz S Chembiochem; 2021 Jul; 22(13):2266-2274. PubMed ID: 33647186 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of monoacyl A-ring precursors of 1alpha,25-dihydroxyvitamin D3 through selective enzymatic hydrolysis. Gotor-Fernández V; Ferrero M; Fernández S; Gotor V J Org Chem; 2002 Feb; 67(4):1266-70. PubMed ID: 11846672 [TBL] [Abstract][Full Text] [Related]
59. 1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action. Ray R; Lambert JR Bioorg Med Chem Lett; 2011 Apr; 21(8):2537-40. PubMed ID: 21392983 [TBL] [Abstract][Full Text] [Related]
60. Relationship between total vitamin D metabolites and complications in patients with type 2 diabetes. Ahmed LHM; Butler AE; Dargham SR; Latif A; Ahmed EA; Hassan A; Atkin SL Biomed Rep; 2021 Jan; 14(1):18. PubMed ID: 33365128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]